Main > ONCOLOGY (**) > Kidney Cancer>RCC>MET *** > Treatment > USA. A. Tivozanib ***

---

USA. A. Tivozanib ***'s subsections
(*) EU Approval Date: 2017. 08.28
(*) EU Launch Date: 2017. 11.15
(*) USA Approval Date: 2021. 03.10
Companion Diagnostics>
Company
Company Licensee EU:
Discovered By:
Mechanism: VEGF Inhibition
TradeMark
TradeMark Web-Site

USA. A. Tivozanib ***'s products
This section has no products